Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12105498 | PMC |
| http://dx.doi.org/10.1016/j.cjco.2025.02.018 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Balloon-Predilatation Followed by Transcatheter Aortic Valve (TAV)-in-TAV Procedure for Transvalvular and Paravalvular Regurgitation.
CJC Open
May 2025
Centre for Cardiovascular Innovation, St Paul's and Vancouver General Hospital, Vancouver, British Columbia, Canada.
Transapical vs. Transaxillary Access in Transcatheter Aortic Valve Implantation: Comparative Mortality and Long-Term Outcomes Using Inverse Probability of Treatment Weighting Analysis.
J Clin Med
March 2025
Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, 10117 Berlin, Germany.
Transcatheter aortic valve implantation (TAVI) is the treatment of choice for symptomatic aortic stenosis in patients with moderate to high surgical risk. When transfemoral access is unsuitable, alternative routes such as transapical (TAP) or transaxillary (TAX) routes must be considered. This study compares the in-hospital mortality and clinical outcomes of TAP vs.
View Article and Find Full Text PDFRecovery rate from conduction disorders in patients with permanent pacemaker implantation after transcatheter aortic valve implantation.
Open Heart
September 2024
Department of Cardiovascular Surgery, The Sakakibara Heart Institute, Okayama, Japan.
Backgrounds: Permanent pacemaker implantation (PPMI) is one of the greatest disadvantages of transcatheter aortic valve implantation (TAVI). To seek the predictors and clinical impacts of PPMI and investigate the recovery rate from conduction disorders.
Methods: We retrospectively analysed data from 745 consecutive patients who underwent TAVI for severe aortic stenosis from November 2013 to July 2022.
Transcatheter aortic valve implantation with self-expanding valves and the impact of balloon predilatation: The DIRECT II trial.
Hellenic J Cardiol
June 2024
First Department of Cardiology, National and Kapodistrian University, "Hippokration" Hospital, Athens, Greece.
Impact of balloon predilatation in patients with reduced versus preserved ejection fraction during transcatheter aortic valve implantation.
Asian Cardiovasc Thorac Ann
November 2022
Cardiology Department, Assiut University Heart Hospital, 68797Assiut University, Assiut, Egypt.
Background: Although there is a trend toward direct transcatheter aortic valve implantation (TAVI), still balloon predilatation is necessary in some cases, especially in patients with severe calcification. However, predilatation including rapid ventricular pacing may have adverse outcomes, especially in patients with reduced ejection factor (EF).
Objective: To evaluate the impact of predilatation on in-hospital outcomes in patients with reduced versus preserved EF underwent TAVI.